Risk of myocardial infarction in trials with Dipeptidyl Peptidase-4 inhibitors: Is duration of study a real issue?

被引：4
作者：
Dicembrini, Ilaria [1 ]
Mannucci, Edoardo [1 ]
机构：
[1] Careggi Teaching Hosp, Diabetol, Florence, Italy
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 184卷
关键词：
Type; 2; diabetes; Myocardial infarction; Dipeptidyl Peptidase 4 inhibitors; METAANALYSIS;
D O I：
10.1016/j.ijcard.2015.02.034
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：543 / 544
页数：2
相关论文
共 50 条
  • [1] Dipeptidyl peptidase-4 inhibitors and pancreatitis risk: a meta-analysis of randomized clinical trials
    Monami, M.
    Dicembrini, I.
    Mannucci, E.
    DIABETES OBESITY & METABOLISM, 2014, 16 (01) : 48 - 56
  • [2] Predictors of response to dipeptidyl peptidase-4 inhibitors: evidence from randomized clinical trials
    Monami, Matteo
    Cremasco, Francesco
    Lamanna, Caterina
    Marchionni, Niccolo
    Mannucci, Edoardo
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2011, 27 (04) : 362 - 372
  • [3] Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials
    Monami, Matteo
    Dicembrini, Ilaria
    Martelli, Daniele
    Mannucci, Edoardo
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 : 57 - 64
  • [4] Renal outcomes with dipeptidyl peptidase-4 inhibitors
    Scheen, A. J.
    Delanaye, P.
    DIABETES & METABOLISM, 2018, 44 (02) : 101 - 111
  • [5] Dipeptidyl peptidase-4 inhibitors as new tools for cardioprotection
    Rankovic, Marina
    Jeremic, Nevena
    Srejovic, Ivan
    Radonjic, Katarina
    Stojanovic, Aleksandra
    Glisic, Milos
    Bolevich, Stefani
    Bolevich, Sergey
    Jakovljevic, Vladimir
    HEART FAILURE REVIEWS, 2021, 26 (02) : 437 - 450
  • [6] Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes
    Ahren, Bo
    EXPERT OPINION ON EMERGING DRUGS, 2008, 13 (04) : 593 - 607
  • [7] Synthesis of dipeptidyl peptidase-4 inhibitors: a brief overview
    Mulakayala, Naveen
    Reddy, Upendar C. H.
    Iqbal, Javed
    Pal, Manojit
    TETRAHEDRON, 2010, 66 (27-28) : 4919 - 4938
  • [8] Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials
    Monami, M.
    Ahren, B.
    Dicembrini, I.
    Mannucci, E.
    DIABETES OBESITY & METABOLISM, 2013, 15 (02) : 112 - 120
  • [9] Dipeptidyl peptidase-4 inhibitors versus sulfonylureas on the top of metformin in patients with diabetes and acute myocardial infarction
    Her, Ae-Young
    Choi, Byoung Geol
    Rha, Seung-Woon
    Kim, Yong Hoon
    Jeong, Myung Ho
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2024, 14 (01) : 38 - 50
  • [10] Cardiovascular effects of dipeptidyl peptidase-4 inhibitors
    Papagianni, M.
    Tziomalos, K.
    HIPPOKRATIA, 2015, 19 (03) : 195 - 199
12345